Gastroenteritis Clinical Trial
Official title:
Is Electrolyte Maintenance Solution Required in Low-Risk Children With Gastroenteritis?
Verified date | April 2018 |
Source | The Hospital for Sick Children |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of this study is to clarify the current standard of care by determining if Electrolyte Maintenance Solution (EMS) is truly the optimal fluid to be used in low-risk children who present to an Emergency Department (ED) with < 72 hours of vomiting or diarrhea.
Status | Completed |
Enrollment | 624 |
Est. completion date | May 2015 |
Est. primary completion date | May 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Months to 60 Months |
Eligibility |
Inclusion Criteria: - =3 episodes of vomiting or diarrhea in preceding 24 hours - Duration of illness less than 96 hours - Age 6 - 60 months - Clinical suspicion of acute intestinal infectious process - Weight = 8 kg - Clinical dehydration score < 5 - Capillary refill < 2 seconds - Absence of bulging fontanelle - Absence of bilious vomiting - Absence of blood in diarrhea/emesis - Absence of abdominal pain (if present reported as periumbilical in location) - Absence of abdominal distention - Absence of acute disease currently requiring treatment - Absence of co-existing diseases (prematurity, cardiac, renal, neurological, metabolic, endocrine, immunodeficiency, trauma or history of ingestion) Exclusion Criteria: - Known gastrointestinal diseases (ie. inflammatory bowel disease, celiac) or any other underlying disease process that might place the child at an increased risk of treatment failure. - Age < 6 months - Weight < 8 kg - If premature, corrected gestational age < 30 weeks - Presence of hematochezia - Responsible physician judges the child requires immediate intravenous rehydration - English language is so limited that consent and/or follow-up is not possible. - Non-Ontario resident [Canadian Institute for Health Information (CIHI) follow-up data will not be available] |
Country | Name | City | State |
---|---|---|---|
Canada | The Hospital for Sick Children | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
The Hospital for Sick Children |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Proportion of children experiencing a treatment failure | This outcome will be deemed to have occurred if any of the following occur: Requires an unscheduled visit after the initial encounter Requires physician evaluation during a follow-up assessment. Hospitalization or Intravenous Rehydration Extended Symptomatology Failure to consume sufficient study fluid during the initial ED visit |
Within 7 days of enrolment | |
Secondary | Percent Weight Change | 72-84 hours after enrolment | ||
Secondary | Proportion of Subjects Receiving Intravenous Rehydration | 7 days | ||
Secondary | Proportion of Subjects Requiring Hospitalization | 7 days | ||
Secondary | Frequency of diarrhea and vomiting episodes | 7 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01168401 -
Bivalent Norovirus Vaccine Study
|
Phase 1 | |
Completed |
NCT02541695 -
Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli
|
N/A | |
Completed |
NCT02473887 -
Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting
|
Phase 1 | |
Completed |
NCT01911143 -
A Retrospective, Blinded Validation of a Host-response Based Diagnostics
|
N/A | |
Not yet recruiting |
NCT01671137 -
Probiotic for the Prevention of Functional Disorders in Childhood
|
N/A | |
Completed |
NCT01917461 -
Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections
|
N/A | |
Withdrawn |
NCT00691275 -
Efficacy Study of IV Fluids Only vs Ondansetron to Treat Dehydration
|
N/A | |
Recruiting |
NCT06025695 -
Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks
|
Phase 3 | |
Completed |
NCT04463082 -
Non-invasive Assessment of the Current State of Hydration in Children by Ultrasound
|
N/A | |
Completed |
NCT02497417 -
A Multi-Site Clinical Evaluation of the ARIES Clostridium Difficile Assay in Symptomatic Patients
|
N/A | |
Active, not recruiting |
NCT03000296 -
Autologous Unselected Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease
|
N/A | |
Completed |
NCT01225042 -
The Effect of Probiotics on E. Coli Gastroenteritis
|
N/A | |
Completed |
NCT01236066 -
Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia
|
N/A | |
Recruiting |
NCT00987519 -
Viral Respiratory and Gastrointestinal Infections in Children Under 6 Years of Age
|
N/A | |
Terminated |
NCT01357174 -
ROTATEQâ„¢ Post-Marketing Surveillance in the Philippines
|
N/A | |
Completed |
NCT01033799 -
Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers
|
N/A | |
Recruiting |
NCT01363726 -
Surveillance of Rotavirus Gastroenteritis in Children <5 Years
|
N/A | |
Completed |
NCT00130832 -
Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED)
|
Phase 3 | |
Terminated |
NCT02568189 -
Utility of Ultrasound Assessment of the Inferior Vena Cava in Patients With Sepsis and Dehydration
|
N/A | |
Terminated |
NCT02165813 -
Oral Nitazoxanide in Acute Gastroenteritis in Australian Indigenous Children
|
Phase 2/Phase 3 |